Revive Therapeutics Ltd (31R) Stock Price & News

31R:FRA

Revive Therapeutics Ltd

0,010 €

0,00%

(0,00) 1D

9-окт., 20:15:12 GMT+2 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 31R...

Mkt. cap

10,49 млн

Avg. vol.

2,94 миң

Volume

0,00

52-wk high

0,06 €

52-wk low

0,00 €

Mkt. cap

10,49 млн

Avg. vol.

2,94 миң

Volume

0,00

52-wk high

0,06 €

52-wk low

0,00 €

News stories

From web sources and news partners

Simply Wall Street

11 мүнөт мурун

Arm Holdings (ARM) On Jury Verdict Watch And A Valuation Debate

MarketBeat

44 мүнөт мурун

AMERISAFE (NASDAQ:AMSF) Stock Rating Raised to Hold at Wall Street Zen

TipRanks

52 мүнөт мурун

Yuanta Securities Details Under-Subscribed S&P 500-Linked ELB Issue

Yahoo Finance

2 саат мурун

Dow, S&P 500, Nasdaq Futures Climb After Oil In Focus As Trump Declares ‘Energy Ceasefire’ Between Russia And Ukraine: IREN, WFF, VSTM, CIFR Stocks In Focus

About Revive Therapeutics Ltd

CEO-

Employees-

Founded2012

HeadquartersТоронто, Онтарио, Канада

SectorPharmaceutical industry

Websiterevivethera.com

All values in CAD	2025-ж. июн.	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	336,32 миң	200,14 миң	283,25 миң	242,05 миң
Operating expense	336,39 миң	220,13 миң	283,30 миң	463,87 миң
Total operating expenses	336,39 миң	220,13 миң	283,30 миң	463,87 миң
Operating income	-336,39 миң	-220,13 миң	-283,30 миң	-463,87 миң
Other non operating income	73,85 миң	-	-	-
EBT including unusual items	-9,60 млн	-281,75 миң	-238,72 миң	-506,50 миң
EBT excluding unusual items	-143,94 миң	-281,75 миң	-234,70 миң	-506,50 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9,60 млн	-281,75 миң	-238,72 миң	-506,50 миң
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	277,00	-	-
Interest expense	-	-	-	-
Net interest expenses	-	277,00	-	-
Depreciation and amortization charges	62,00	46,00	48,00	47,00
EBITDA	-336,32 миң	-220,08 миң	-283,25 миң	-463,82 миң
Gain or loss from assets sale	-	-	-	-

Ask anything